(HS Neilson 096246 2022) Psychedelic Harm Reduction and Integration in Clinical Practice
Tracking # 20-942626
Course overview
What do you do when a client lets you know they are going to use psychedelics on their own, as part of a ceremony, spiritual practice or because they've heard it can help them? Is there anything you can do to help reduce harm? And what about micro-dosing, which is gaining popularity? Psychedelic Harm Reduction and Integration (PHRI) is a transdiagnostic and transtheoretical approach that YOU as a mental health professional can take to having conversations with people who have taken psychedelics in clinical or non-clinical settings, or who are seeking help at any stage of psychedelic use. This recording will cover the core concepts of PHRI and its applications, including discussions about microdosing, responding to requests for referrals to non-licensed providers, and working with difficult experiences.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling
Certified Master Social Worker
Licensed Clinical Social Worker
Licensed Marriage and Family Therapist
Licensed Mental Health Counselor
Florida Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
Florida Board of Psychology
Limited License Psychologist
Psychologist
Disclosure statements
Speaker Disclosures:
Financial: Elizabeth Nielson is the co-founder of Fluence and has employment relationships with Columbia University Irving Medical Center, New York State Psychiatric Institute, and MAPS NY Private Practice Research Site. She receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Elizabeth Nielson is the founding member and an advisory board member of the Psychedelic Medicine Association. She is a member of the American Psychological Association and the International Society for Research on Psychedelics.